Researchers Identify New Congenital Disorder of Glycosylation, GALNT2-CDG
Dakota Campbell
Tue, 05/26/2020 - 12:00
Seven patients now have a name for their specific congenital disorder of glycosylation (CDG)—a new type called GALNT2-CDG. Researchers from Frontiers in Congenital Disorders of Glycosylation (FCDGC) describe the new disorder, caused by mutations in the GALNT2 gene, in the journal Brain.